Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Dyslipidemia

  Free Subscription


Articles published in Ann Intern Med

Retrieve available abstracts of 31 articles:
HTML format



Single Articles


    November 2020
  1. BAILEY AL, Campbell CL
    The U.S. Department of Veterans Affairs and U.S. Department of Defense Guideline for the Management of Dyslipidemia: Is Moderate Risk Reduction Enough?
    Ann Intern Med. 2020;173:846-847.
    PubMed    


  2. LUTZ J, Dunaj-Kazmierowska M, Arcan S, Kassner U, et al
    Chylomicronemia From GPIHBP1 Autoantibodies Successfully Treated With Rituximab: A Case Report.
    Ann Intern Med. 2020;173:764-765.
    PubMed    


    September 2020
  3. RESTON JT, Buelt A, Donahue MP, Neubauer B, et al
    Interventions to Improve Statin Tolerance and Adherence in Patients at Risk for Cardiovascular Disease : A Systematic Review for the 2020 U.S. Department of Veterans Affairs and U.S. Department of Defense Guidelines for Management of Dyslipidemia.
    Ann Intern Med. 2020 Sep 22. doi: 10.7326/M20-4680.
    PubMed     Abstract available


  4. O'MALLEY PG, Arnold MJ, Kelley C, Spacek L, et al
    Management of Dyslipidemia for Cardiovascular Disease Risk Reduction: Synopsis of the 2020 Updated U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guideline.
    Ann Intern Med. 2020 Sep 22. doi: 10.7326/M20-4648.
    PubMed     Abstract available


    August 2020
  5. TARTOF SY, Qian L, Hong V, Wei R, et al
    Obesity and Mortality Among Patients Diagnosed With COVID-19: Results From an Integrated Health Care Organization.
    Ann Intern Med. 2020 Aug 12. doi: 10.7326/M20-3742.
    PubMed     Abstract available


    June 2020
  6. BREAZZANO MP, Chen RWS
    Scleritis With Uveal Effusion From Alirocumab.
    Ann Intern Med. 2020;172:834-836.
    PubMed    


    May 2020
  7. LAZARTE J, Hegele RA
    Regression of Xanthelasmas With Statin Treatment in a Normolipidemic Patient.
    Ann Intern Med. 2020;172:701-702.
    PubMed    


    April 2020
  8. UEDA M, Burke FM, Remaley AT, Hegele RA, et al
    Familial Chylomicronemia Syndrome With a Novel Homozygous LPL Mutation Identified in Three Siblings in Their 50s.
    Ann Intern Med. 2020;172:500-502.
    PubMed    


    January 2020
  9. CARNICELLI AP, Granger CB
    In patients with recent ACS and uncontrolled dyslipidemia, alirocumab reduced MACE regardless of previous CABG.
    Ann Intern Med. 2020;172:JC3.
    PubMed    


    November 2019
  10. SMITH DA
    Review: In dyslipidemia or atherosclerotic CVD, alirocumab and evolocumab vs control each reduce MI and stroke.
    Ann Intern Med. 2019;171:JC56.
    PubMed    


    July 2019
  11. ELHASSAN YS, Alahdab F, Prete A, Delivanis DA, et al
    Natural History of Adrenal Incidentalomas With and Without Mild Autonomous Cortisol Excess: A Systematic Review and Meta-analysis.
    Ann Intern Med. 2019;171:107-116.
    PubMed     Abstract available


  12. DE DIOS GARCIA-DIAZ J, Corral-Bueno IM, Mesa-Latorre JM, Lozano-Duran C, et al
    Proprotein Convertase Subtilisin/Kexin Type 9 Antibody and Statin-Associated Autoimmune Myopathy.
    Ann Intern Med. 2019;171:68-69.
    PubMed    


    June 2019
  13. GRUNDY SM, Stone NJ
    2018 Cholesterol Clinical Practice Guidelines: Synopsis of the 2018 American Heart Association/American College of Cardiology/Multisociety Cholesterol Guideline.
    Ann Intern Med. 2019;170:779-783.
    PubMed     Abstract available


    May 2019
  14. CHAIT A, Eckel RH
    The Chylomicronemia Syndrome Is Most Often Multifactorial: A Narrative Review of Causes and Treatment.
    Ann Intern Med. 2019;170:626-634.
    PubMed     Abstract available


    February 2019
  15. KOEHLER P, Brockelmann PJ, Hallek M, Kochanek M, et al
    Bloodletting to Treat Severe Hypertriglyceridemia.
    Ann Intern Med. 2019 Feb 26. pii: 2726672. doi: 10.7326/L18-0706.
    PubMed    


  16. KAZI DS, Penko J, Coxson PG, Guzman D, et al
    Cost-Effectiveness of Alirocumab: A Just-in-Time Analysis Based on the ODYSSEY Outcomes Trial.
    Ann Intern Med. 2019;170:221-229.
    PubMed     Abstract available


    July 2018
  17. STUART JJ, Tanz LJ, Missmer SA, Rimm EB, et al
    Hypertensive Disorders of Pregnancy and Maternal Cardiovascular Disease Risk Factor Development: An Observational Cohort Study.
    Ann Intern Med. 2018 Jul 3. pii: 2686987. doi: 10.7326/M17-2740.
    PubMed     Abstract available



  18. High Blood Pressure During Pregnancy and Development of Risk Factors for Cardiovascular Disease.
    Ann Intern Med. 2018 Jul 3. pii: 2686989. doi: 10.7326/P18-0008.
    PubMed    


    April 2018
  19. CHAMBERLAIN JJ, Johnson EL, Leal S, Rhinehart AS, et al
    Cardiovascular Disease and Risk Management: Review of the American Diabetes Association Standards of Medical Care in Diabetes 2018.
    Ann Intern Med. 2018 Apr 3. pii: 2677350. doi: 10.7326/M18-0222.
    PubMed     Abstract available


    March 2018
  20. SHAPIRO MD, Miles J, Tavori H, Fazio S, et al
    Diagnosing Resistance to a Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor.
    Ann Intern Med. 2018;168:376-379.
    PubMed    


    January 2018
  21. RAVI D, Ghasemiesfe M, Korenstein D, Cascino T, et al
    Associations Between Marijuana Use and Cardiovascular Risk Factors and Outcomes: A Systematic Review.
    Ann Intern Med. 2018 Jan 23. pii: 2670319. doi: 10.7326/M17-1548.
    PubMed     Abstract available


    December 2017
  22. KOPIN L, Lowenstein C
    Dyslipidemia.
    Ann Intern Med. 2017;167:ITC81-ITC96.
    PubMed     Abstract available


  23. BURNS RB, Graham K, Sawhney MS, Reynolds EE, et al
    Should This Patient Receive Aspirin?: Grand Rounds Discussion From Beth Israel Deaconess Medical Center.
    Ann Intern Med. 2017;167:786-793.
    PubMed     Abstract available


    August 2017
  24. NISSEN SE
    Statin Denial: An Internet-Driven Cult With Deadly Consequences.
    Ann Intern Med. 2017;167:281-282.
    PubMed    


    July 2017
  25. STAHEL P, Xiao C, Hegele RA, Lewis GF, et al
    Polygenic Risk for Hypertriglyceridemia Can Mimic a Major Monogenic Mutation.
    Ann Intern Med. 2017 Jul 25. doi: 10.7326/L17-0182.
    PubMed    


    June 2017
  26. RIDKER PM, Cook NR
    Cholesterol Evaluation in Young Adults: Absence of Clinical Trial Evidence Is Not a Reason to Delay Screening.
    Ann Intern Med. 2017;166:901-902.
    PubMed    


    May 2017
  27. PATEL KK, Taksler GB, Hu B, Rothberg MB, et al
    Prevalence of Elevated Cardiovascular Risks in Young Adults: A Cross-sectional Analysis of National Health and Nutrition Examination Surveys.
    Ann Intern Med. 2017 May 16. doi: 10.7326/M16-2052.
    PubMed     Abstract available


    January 2017
  28. LAUFFENBURGER JC, Shrank WH, Bitton A, Franklin JM, et al
    Association Between Patient-Centered Medical Homes and Adherence to Chronic Disease Medications: A Cohort Study.
    Ann Intern Med. 2017;166:81-88.
    PubMed     Abstract available


    October 2016
  29. COOK NR, Ridker PM
    Calibration of the Pooled Cohort Equations for Atherosclerotic Cardiovascular Disease: An Update.
    Ann Intern Med. 2016 Oct 11. doi: 10.7326/M16-1739.
    PubMed     Abstract available


    September 2016
  30. KHANJI MY, Bicalho VV, van Waardhuizen CN, Ferket BS, et al
    Cardiovascular Risk Assessment: A Systematic Review of Guidelines.
    Ann Intern Med. 2016 Sep 13. doi: 10.7326/M16-1110.
    PubMed     Abstract available


    March 2016
  31. NAVARESE EP, Kolodziejczak M, Kereiakes DJ, Tantry US, et al
    Proprotein Convertase Subtilisin/Kexin Type 9 Monoclonal Antibodies for Acute Coronary Syndrome: A Narrative Review.
    Ann Intern Med. 2016 Mar 22. doi: 10.7326/M15-2994.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Dyslipidemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: